Oramed Pharmaceuticalsals, Phase 1B Clinical Trials of Oral Insulin Capsule

March 11, 2008 - Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a developer of oral delivery systems, has successfully completed Phase 1B clinical trials of its oral insulin capsule. The Phase 1B trial, which utilized healthy volunteers, was focused on finding the optimal dosage for the formulation of Oramed’s oral insulin product... [PDF] Oramed 's Press Release -